Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1958 1
1967 1
1980 1
2003 1
2018 2
2019 7
2020 4
2021 5
2022 9
2023 18
2024 10

Text availability

Article attribute

Article type

Publication date

Search Results

57 results

Results by year

Filters applied: . Clear all
Page 1
p53 is a central regulator driving neurodegeneration caused by C9orf72 poly(PR).
Maor-Nof M, Shipony Z, Lopez-Gonzalez R, Nakayama L, Zhang YJ, Couthouis J, Blum JA, Castruita PA, Linares GR, Ruan K, Ramaswami G, Simon DJ, Nof A, Santana M, Han K, Sinnott-Armstrong N, Bassik MC, Geschwind DH, Tessier-Lavigne M, Attardi LD, Lloyd TE, Ichida JK, Gao FB, Greenleaf WJ, Yokoyama JS, Petrucelli L, Gitler AD. Maor-Nof M, et al. Among authors: nakayama l. Cell. 2021 Feb 4;184(3):689-708.e20. doi: 10.1016/j.cell.2020.12.025. Epub 2021 Jan 21. Cell. 2021. PMID: 33482083 Free PMC article.
Targeting RTN4/NoGo-Receptor reduces levels of ALS protein ataxin-2.
Rodriguez CM, Bechek SC, Jones GL, Nakayama L, Akiyama T, Kim G, Solow-Cordero DE, Strittmatter SM, Gitler AD. Rodriguez CM, et al. Among authors: nakayama l. Cell Rep. 2022 Oct 25;41(4):111505. doi: 10.1016/j.celrep.2022.111505. Cell Rep. 2022. PMID: 36288715 Free PMC article.
Sociodemographic disparities in ophthalmological clinical trials.
Nakayama LF, Mitchell WG, Shapiro S, Santiago APD, Phanphruk W, Kalua K, Celi LA, Regatieri CVS. Nakayama LF, et al. BMJ Open Ophthalmol. 2023 Feb;8(1):e001175. doi: 10.1136/bmjophth-2022-001175. BMJ Open Ophthalmol. 2023. PMID: 37278426 Free PMC article. Review.
Artificial intelligence in uveitis: A comprehensive review.
Nakayama LF, Ribeiro LZ, Dychiao RG, Zamora YF, Regatieri CVS, Celi LA, Silva P, Sobrin L, Belfort R Jr. Nakayama LF, et al. Surv Ophthalmol. 2023 Jul-Aug;68(4):669-677. doi: 10.1016/j.survophthal.2023.02.007. Epub 2023 Mar 4. Surv Ophthalmol. 2023. PMID: 36878360 Review.
Artificial intelligence for telemedicine diabetic retinopathy screening: a review.
Nakayama LF, Zago Ribeiro L, Novaes F, Miyawaki IA, Miyawaki AE, de Oliveira JAE, Oliveira T, Malerbi FK, Regatieri CVS, Celi LA, Silva PS. Nakayama LF, et al. Ann Med. 2023;55(2):2258149. doi: 10.1080/07853890.2023.2258149. Epub 2023 Sep 21. Ann Med. 2023. PMID: 37734417 Free PMC article. Review.
BOLD: Blood-gas and Oximetry Linked Dataset.
Matos J, Struja T, Gallifant J, Nakayama L, Charpignon ML, Liu X, Economou-Zavlanos N, S Cardoso J, Johnson KS, Bhavsar N, Gichoya J, Celi LA, Wong AI. Matos J, et al. Among authors: nakayama l. Sci Data. 2024 May 24;11(1):535. doi: 10.1038/s41597-024-03225-z. Sci Data. 2024. PMID: 38789452 Free PMC article.
Clinical validation of a smartphone-based retinal camera for diabetic retinopathy screening.
de Oliveira JAE, Nakayama LF, Zago Ribeiro L, de Oliveira TVF, Choi SNJH, Neto EM, Cardoso VS, Dib SA, Melo GB, Regatieri CVS, Malerbi FK. de Oliveira JAE, et al. Among authors: nakayama lf. Acta Diabetol. 2023 Aug;60(8):1075-1081. doi: 10.1007/s00592-023-02105-z. Epub 2023 May 7. Acta Diabetol. 2023. PMID: 37149834 Free PMC article.
57 results